Linkage and genome-wide association studies have mapped several regions in human genome associated with AD risk [4]: specific genes, such as APOE and BACE1/2, are thought to be prime candidates to confer risk because of their role in pathways involving Aβ biosynthesis and deposition [5]. This evidence concerns the gene BACE1 and Alzheimer disease.